Skip to main content
. 2004 Jan;48(1):116–123. doi: 10.1128/AAC.48.1.116-123.2004

TABLE 1.

Summary of dosages and dosing

Group Treatment period 1 (days 1-28)a Treatment period 2 (days 29-42)a
1 908, 1,395 mg BID APV, 1,200 mg BID
2 APV, 1,200 mg BID 908, 1,395 mg BID
3 908, 1,860 mg BID APV, 1,200 mg BID
4 APV, 1,200 mg BID 908, 1,860 mg BID
a

908 and APV were both administered in combination with abacavir (300 mg BID) and lamivudine (150 mg BID).